| [1] |
Hameed BMZ, S Dhavileswarapu AVL, Raza S Z, et al. Artificial intelligence and its impact on urological diseases and management: a comprehensive review of the literature[J]. J Clin Med, 2021, 10(9): 1864.
|
| [2] |
Rashidian N, Abu Hilal M. Applications of machine learning in surgery: ethical considerations[J]. Artif Intell Surg, 2022, 2(1):18-23.
|
| [3] |
Kolben Y, Azmanov H, Gelman R, et al. Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections[J]. Ann Med, 2023, 55(1): 311-318.
|
| [4] |
Wang YF, Mao L, Chen HJ, et al. Predicting cognitive impairment in chronic kidney disease patients using structural and functional brain network: an application study of artificial intelligence[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2023, 122: 110677.
|
| [5] |
Manimaran M, Arora A, Lovejoy CA, et al. Role of artificial intelligence and machine learning in haematology[J]. J Clin Pathol, 2022, 75(9): 585-587.
|
| [6] |
Biswas N, Chakrabarti S. Artificial intelligence (AI)-based systems biology approaches in multi-omics data analysis of cancer[J]. Front Oncol, 2020, 10: 588221.
|
| [7] |
Bertoni G, Rotunno E, Marsmans D, et al. Near-real-time diagnosis of electron optical phase aberrations in scanning transmission electron microscopy using an artificial neural network[J]. Ultramicroscopy, 2023, 245: 113663.
|
| [8] |
De Fauw J, Ledsam JR, Romera-Paredes B, et al. Clinically applicable deep learning for diagnosis and referral in retinal disease[J]. Nat Med, 2018, 24(9): 1342-1350.
|
| [9] |
Delpino FM, Costa ÂK, Farias S R, et al. Machine learning for predicting chronic diseases: a systematic review[J]. Public Health, 2022, 205: 14-25.
|
| [10] |
Hinton G. Deep learning-a technology with the potential to transform health care[J]. JAMA, 2018, 320(11): 1101-1102.
|
| [11] |
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018[J]. Eur J Cancer, 2018, 103: 356-387.
|
| [12] |
Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma[J]. World J Oncol, 2020, 11(3): 79-87.
|
| [13] |
Kunapuli G, Varghese BA, Ganapathy P, et al. A decision-support tool for renal mass classification[J]. J Digit Imaging, 2018, 31(6): 929-939.
|
| [14] |
Li X, Ma Q, Nie P, et al. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study[J]. Br J Radiol, 2022, 95(1129): 20210534.
|
| [15] |
Xu Q, Zhu Q, Liu H, et al. Differentiating benign from malignant renal tumors using T2- and diffusion-weighted images: a comparison of deep learning and radiomics models versus assessment from radiologists[J]. J Magn Reson Imaging, 2022, 55(4): 1251-1259.
|
| [16] |
Kocak B, Durmaz ES, Ates E, et al. Radiogenomics in clear cell renal cell carcinoma: machine learning-based high-dimensional quantitative CT texture analysis in predicting PBRM1 mutation status[J]. AJR Am J Roentgenol, 2019, 212(3): W55-W63.
|
| [17] |
Ding J, Xing Z, Jiang Z, et al. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma[J]. Eur J Radiol, 2018, 103: 51-56.
|
| [18] |
Zhao B, Waterman RS, Urman RD, et al. A machine learning approach to predicting case duration for robot-assisted surgery[J]. J Med Syst, 2019, 43(2): 32.
|
| [19] |
Haifler M, Pence I, Ristau B, et al. Discrimination of malignant and benign kidney tissue with 1064 nm dispersive Raman spectroscopy[J]. Eur Urol Suppl, 2017, 16(3): e1345-e1346.
|
| [20] |
Li P, Ren H, Zhang Y, et al. Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma[J]. Medicine, 2018, 97(33): e11839.
|
| [21] |
Kim H, Lee SJ, Park SJ, et al. Machine learning approach to predict the probability of recurrence of renal cell carcinoma after surgery: prediction model development study[J]. JMIR Med Inform, 2021, 9(3): e25635.
|
| [22] |
Buchner A, Kendlbacher M, Nuhn P, et al. Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networks[J]. Clin Genitourin Cancer, 2012, 10(1): 37-42.
|
| [23] |
Teoh JYC, Huang J, Ko WYK, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita[J]. Eur Urol, 2020, 78(6): 893-906.
|
| [24] |
Chang TC, Marcq G, Kiss B, et al. Image-guided transurethral resection of bladder tumors - current practice and future outlooks[J]. Bladder Cancer, 2017, 3(3): 149-159.
|
| [25] |
Shkolyar E, Jia X, Chang TC, et al. Augmented bladder tumor detection using deep learning[J]. Eur Urol, 2019, 76(6): 714-718.
|
| [26] |
Zhang X, Xu X, Tian Q, et al. Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging[J]. J Magn Reson Imaging, 2017, 46(5): 1281-1288.
|
| [27] |
Eminaga O, Eminaga N, Semjonow A, et al. Diagnostic classification of cystoscopic images using deep convolutional neural networks[J]. JCO Clin Cancer Inform, 2018, 2: 1-8.
|
| [28] |
Posielski N, Koenig H, Ho O, et al. Use of neoadjuvant chemotherapy in elderly patients with muscle-invasive bladder cancer: a population-based study, 2006-2017[J]. Oncology, 2022, 36(1): 21-33.
|
| [29] |
Patel HD, Patel SH, Blanco-Martinez E, et al. Four versus 3 cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: implications for pathological response and survival[J]. J Urol, 2022, 207(1): 77-85.
|
| [30] |
Cha KH, Hadjiiski LM, Cohan RH, et al. Diagnostic accuracy of CT for prediction of bladder cancer treatment response with and without computerized decision support[J]. Acad Radiol, 2019, 26(9): 1137-1145.
|
| [31] |
Cha KH, Hadjiiski LM, Samala RK, et al. Bladder cancer segmentation in CT for treatment response assessment: application of deep-learning convolution neural network-a pilot study[J]. Tomography, 2016, 2(4): 421-429.
|
| [32] |
Bhambhvani HP, Zamora A, Shkolyar E, et al. Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer[J]. Urol Oncol, 2021, 39(3): 193.e7-193193.e12.
|
| [33] |
Hasnain Z, Mason J, Gill K, et al. Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients[J]. PLoS One, 2019, 14(2): e0210976.
|
| [34] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| [35] |
程贤文, 邹晓凤, 赖伟建. 弥散加权成像纹理特征分析对不同级别前列腺癌鉴别诊断的临床价值[J]. 泌尿外科杂志(电子版), 2023, 15(3): 18-21.
|
| [36] |
Ishioka J, Matsuoka Y, Uehara S, et al. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm[J]. BJU Int, 2018, 122(3): 411-417.
|
| [37] |
Epstein JI. An update of the Gleason grading system[J]. J Urol, 2010, 183(2): 433-440.
|
| [38] |
Bulten W, Pinckaers H, van Boven H, et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study[J]. Lancet Oncol, 2020, 21(2): 233-241.
|
| [39] |
Nagpal K, Foote D, Liu Y, et al. Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer[J]. NPJ Digit Med, 2019, 7:2:48.
|
| [40] |
Auffenberg GB, Ghani KR, Ramani S, et al. askMUSIC: leveraging a clinical registry to develop a new machine learning model to inform patients of prostate cancer treatments chosen by similar men[J]. Eur Urol, 2019, 75(6): 901-907.
|
| [41] |
Abdollahi H, Mofid B, Shiri I, et al. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, gleason score and stage in prostate cancer[J]. Radiol Med, 2019, 124(6): 555-567.
|
| [42] |
Hung AJ, Chen J, Che Z, et al. Utilizing machine learning and automated performance metrics to evaluate robot-assisted radical prostatectomy performance and predict outcomes[J]. J Endourol, 2018, 32(5): 438-444.
|
| [43] |
Hung AJ, Chen J, Ghodoussipour S, et al. A deep-learning model using automated performance metrics and clinical features to predict urinary continence recovery after robot-assisted radical prostatectomy[J]. BJU Int, 2019, 124(3): 487-495.
|
| [44] |
Wong NC, Lam C, Patterson L, et al. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy[J]. BJU Int, 2019, 123(1): 51-57.
|
| [45] |
Chen J, Remulla D, Nguyen JH, et al. Current status of artificial intelligence applications in urology and their potential to influence clinical practice[J]. BJU Int, 2019, 124(4): 567-577.
|
| [46] |
Schneider L, Laiouar-Pedari S, Kuntz S, et al. Integration of deep learning-based image analysis and genomic data in cancer pathology: a systematic review[J]. Eur J Cancer, 2022, 160: 80-91.
|